Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer
Otolaryngology–Head and Neck Surgery · 2026-04 · 174 (4) · 1025-1038
DOI: 10.1002/ohn.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 31.01.2026. Verfasst von Mateo Useche und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCD NIH HHS.
Abstract (Originalsprache)
Objective
To understand temporal trends in presentation and survival among patients with early‐onset oral cavity squamous cell carcinoma (EO‐OCSCC). Study Design Retrospective cohort study.
Setting
National Cancer Database (NCDB), 2004 to 2022.
Methods
Adult patients younger than 50 years diagnosed with OCSCC in the NCDB. Annual case distributions by subsite, sex, and stage were modeled with logistic regression, reporting odds ratios (ORs) per calendar year over time. Kaplan‐Meier and Cox proportional hazards analyses assessed 5‐year overall survival (OS), stratified by age group, subsite, and stage.
Results
Among 178,140 OCSCC cases, 21,630 (12.1%) were EO‐OCSCC with median age of 44 years. Tongue was the most common subsite (66.9%) and increased over time (OR/year = 1.03; 95% CI, 1.02‐1.04). Female cases rose steadily (OR/year = 1.01; 95% CI, 1.01‐1.02), narrowing the male‐female gap. Advanced‐stage disease increased by 5% annually in tongue tumors and 3% in non‐tongue tumors. Five‐year OS was higher in tongue (73.7%) than non‐tongue tumors (61.5%, P < .001) and improved over time, with annual reductions in mortality risk of 1.1% for tongue and 1.9% for non‐tongue tumors. By age group, survival was highest for patients 20‐29 years and lowest for those 40‐49 years.
Conclusion
EO‐OCSCC is increasingly presenting as tongue primaries and in female patients, with a rising burden of advanced‐stage disease. Despite this unfavorable shift, survival has improved modestly across subsites, ages, and stages, underscoring the heterogeneity of EO‐OCSCC and the need for earlier detection and awareness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
- Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, Washington, USA.
- Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington, USA.
ORCID-Profile: Mateo Useche
Förderung
- NIDCD NIH HHS
Zitieren
APA
Useche, M., Alkhatib, H. H., Rodriguez, C. P., Shih, L., Liao, J. J., Panjwani, N., Futran, N., Marchiano, E., Ferrandino, R., & Barber, B. (2026). Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer. Otolaryngology–Head and Neck Surgery, 174(4), 1025-1038. https://doi.org/10.1002/ohn.70151
Vancouver
Useche M, Alkhatib HH, Rodriguez CP, Shih L, Liao JJ, Panjwani N, et al. Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer. Otolaryngology–Head and Neck Surgery. 2026;174(4):1025-1038. doi:10.1002/ohn.70151
BibTeX
@article{Useche2026,
author = {Useche, Mateo and Alkhatib, Hosam H and Rodriguez, Cristina P and Shih, Lauren and Liao, Jay J and Panjwani, Neil and Futran, Neal and Marchiano, Emily and Ferrandino, Rocco and Barber, Brittany},
title = {Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
volume = {174},
number = {4},
pages = {1025--1038},
doi = {10.1002/ohn.70151}
}
EUVIMED